Latest Manufacturing News

Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.

Trigg Minerals has completed a conceptual study for a cutting-edge antimony smelter using Metso’s Ausmelt technology, aiming to establish a rare mine-to-metal supply chain in the West. The project promises energy efficiency, environmental responsibility, and rapid development to meet growing US demand.

Imagion Biosystems has reached key milestones in its MagSense® HER2 breast cancer imaging program, including starting manufacturing for its Phase 2 trial and launching an AI imaging protocol collaboration with Wayne State University.

Enova Mining reports significant expansion of near-surface high-grade titanium, rare earth elements, and niobium mineralisation at its CODA Central Project in Brazil, highlighting the project's growing potential as a multi-commodity critical minerals source.

Mayne Pharma has publicly refuted recent media claims about plans to close its Salisbury manufacturing site, clarifying its position amid ongoing regulatory scrutiny of its Scheme transaction with Cosette.

Metal Powder Works Limited has completed a A$15 million institutional placement, strengthening its balance sheet to scale production and expand its market presence.

Elsight has secured a US$5.35 million contract with a European defence OEM, pushing its 2025 orders to US$23.3 million, a staggering 1000% increase over 2024. The company’s rising deliveries and upcoming ASX index inclusions mark a pivotal growth phase.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

DGL Group Limited has issued a corrected FY25 financial presentation, revealing lower EBITDA and NPAT figures due to operational challenges and restructuring costs. Despite revenue growth, the company faces a modified audit opinion on inventory and outlines strategic cost-cutting and growth investments.

Black Canyon Limited has raised $10 million through a share placement to accelerate exploration and development of its promising Wandanya manganese and iron discovery in Western Australia.

Vulcan Energy has inked a pivotal supply contract with Canadian firm NESI for electrolysis technology, advancing its Lionheart Project’s Central Lithium Plant in Frankfurt. This deal marks a crucial step toward finalising project financing and commencing construction in H2 2025.

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.